Risultati della ricerca - Aaron C. Tan
- Mostra 1 - 15 risultati su 15
-
1
Targeting the PI3K/Akt/mTOR pathway in non‐small cell lung cancer (NSCLC) di Aaron C. Tan
Pubblicazione 2020Revisão -
2
Brain Metastases in Lung Cancers with Emerging Targetable Fusion Drivers di Aaron C. Tan, Malinda Itchins, Mustafa Khasraw
Pubblicazione 2020Revisão -
3
-
4
Management of glioblastoma: State of the art and future directions di Aaron C. Tan, David M. Ashley, Giselle Y. López, Michael D. Malinzak, Henry S. Friedman, Mustafa Khasraw
Pubblicazione 2020Revisão -
5
-
6
-
7
-
8
Intratumoral CD39+CD8+ T Cells Predict Response to Programmed Cell Death Protein-1 or Programmed Death Ligand-1 Blockade in Patients With NSCLC di Joe Yeong, Lisda Suteja, Yannick Simoni, Kah Weng Lau, Aaron C. Tan, Hui Hua Li, Sherlly Lim, Jie Hua Loh, Felicia Wee, Sanjna Nilesh Nerurkar, Angela Takano, Eng Huat Tan, Tony Kiat Hon Lim, Evan W. Newell, Daniel S.W. Tan
Pubblicazione 2021Artigo -
9
Systematic review of combinations of targeted or immunotherapy in advanced solid tumors di Aaron C. Tan, Stephen Bagley, Patrick Y. Wen, Michael Lim, Michael Platten, Howard Colman, David M. Ashley, Wolfgang Wick, Susan M. Chang, Evanthia Galanis, Alireza Mansouri, Simon Khagi, Minesh P. Mehta, Amy B. Heimberger, Vinay K. Puduvalli, David A. Reardon, Solmaz Sahebjam, John Simes, Scott Antonia, Don Berry, Mustafa Khasraw
Pubblicazione 2021Revisão -
10
Mechanisms of resistance to selective RET tyrosine kinase inhibitors in RET fusion-positive non-small-cell lung cancer di W. Marston Linehan, Stephen V. Liu, Caroline E. McCoach, Viola W. Zhu, Aaron C. Tan, Satoshi Yoda, Jennifer Peterson, Andrew Do, Kylie Prutisto-Chang, Ibiayi Dagogo‐Jack, Lecia V. Sequist, Lori J. Wirth, Jochen K. Lennerz, Aaron N. Hata, Mari Mino‐Kenudson, Valentina Nardi, S.-H.I. Ou, Daniel Shao-Weng Tan, Justin F. Gainor
Pubblicazione 2020Artigo -
11
Recommendations for the use of next-generation sequencing in patients with metastatic cancer in the Asia-Pacific region: a report from the APODDC working group di Herbert H. Loong, Toshio Shimizu, Amy Prawira, Aaron C. Tan, Ben Tran, Daphne Day, David S.P. Tan, Frederic Ivan L. Ting, Joanne Chiu, Mun N. Hui, Michelle Wilson, Naiyarat Prasongsook, Takafumi Koyama, Thanyanan Reungwetwattana, Tira J. Tan, Valerie Heong, Pei Jye Voon, Sehhoon Park, Iain Beehuat Tan, Stephen L. Chan, Daniel S.W. Tan
Pubblicazione 2023Revisão -
12
Detection of circulating tumor DNA with ultradeep sequencing of plasma cell‐free DNA for monitoring minimal residual disease and early detection of recurrence in early‐stage lung c... di Aaron C. Tan, Gillianne Lai, Stephanie P.L. Saw, Kevin Lee Min Chua, Angela Takano, Boon‐Hean Ong, Tina Koh, Amit Jain, Wan Ling Tan, Quan Sing Ng, Ravindran Kanesvaran, Tanujaa Rajasekaran, Ekaterina Kalashnikova, Derrick Renner, Sumedha Sudhaman, Meenakshi Malhotra, Himanshu Sethi, Minetta C. Liu, Alexey Aleshin, Wan‐Teck Lim, Eng‐Huat Tan, Anders J. Skanderup, Mei‐Kim Ang, Daniel S.W. Tan
Pubblicazione 2024Artigo -
13
Association of Clinicopathologic and Molecular Tumor Features With Recurrence in Resected Early-Stage Epidermal Growth Factor Receptor–Positive Non–Small Cell Lung Cancer di Stephanie P.L. Saw, Siqin Zhou, Jianbin Chen, Gillianne Lai, Mei‐Kim Ang, Kevin Lee Min Chua, Ravindran Kanesvaran, Quan Sing Ng, Amit Jain, Wan Ling Tan, Tanujaa Rajasekaran, Wan‐Teck Lim, Aaron C. Tan, Kam Weng Fong, Angela Takano, Xin Cheng, Kiat Hon Lim, Tina Koh, Boon‐Hean Ong, Eng Huat Tan, Chee‐Keong Toh, Anders J. Skanderup, Sze Huey Tan, Daniel Shao-Weng Tan
Pubblicazione 2021Artigo -
14
Deficiency of the splicing factor RBM10 limits EGFR inhibitor response in EGFR-mutant lung cancer di Shigeki Nanjo, Wei Wu, Niki Karachaliou, Collin M. Blakely, Junji Suzuki, Yu‐Ting Chou, Siraj M. Ali, D. Lucas Kerr, Victor Olivas, Jonathan Shue, Julia Rotow, Manasi K. Mayekar, Franziska Haderk, Nilanjana Chatterjee, Anatoly Urisman, Jia Chi Yeo, Anders J. Skanderup, Aaron C. Tan, Wai Leong Tam, Óscar Arrieta, Kazuyoshi Hosomichi, Akihiro Nishiyama, Seiji Yano, Yuriy Kirichok, Daniel S.W. Tan, Rafael Rosell, Ross A. Okimoto, Trever G. Bivona
Pubblicazione 2022Artigo -
15
Why Calls for More Routine Carotid Stenting Are Currently Inappropriate di Anne L. Abbott, Mark A. Adelman, Andrei V. Alexandrov, P. Alan Barber, Henry J.M. Barnett, Jonathan Beard, Peter Bell, Martin Björck, David Blacker, Leo H. Bonati, Martin M. Brown, Clifford J. Buckley, Richard P. Cambria, John Castaldo, Anthony J. Comerota, E. Sander Connolly, Ronald L. Dalman, Alun H. Davies, Hans‐Henning Eckstein, Rishad M. Faruqi, Thomas E. Feasby, Gustav Fraedrich, Péter Gloviczki, Graeme J. Hankey, Robert E. Harbaugh, Eitan Heldenberg, Michael G. Hennerici, Michael D. Hill, Timothy Kleinig, Dimitri P. Mikhailidis, Wesley S. Moore, Ross Naylor, Andrew Nicolaides, Kosmas I. Paraskevas, David M. Pelz, James W. Prichard, Grant Purdie, Jean‐Baptiste Ricco, Peter A. Ringleb, Thomas S. Riles, Peter M. Rothwell, Peter Sandercock, Henrik Sillesen, J. David Spence, Francesco Spinelli, Jonathon Sturm, Aaron C. Tan, Ankur Thapar, Frank J. Veith, Tissa Wijeratne, Wei Zhou
Pubblicazione 2013Artigo
Strumenti per la ricerca:
Soggetti correlati
Medicine
Internal medicine
Cancer
Oncology
Biology
Cancer research
Lung cancer
Biochemistry
Gene
Clinical trial
Immunotherapy
Intensive care medicine
Chemotherapy
Colorectal cancer
Epidermal growth factor receptor
Health care
Paleontology
Receptor
Retrospective cohort study
Targeted therapy
Bioinformatics
Biopsy
Cell biology
Chemistry
Confidence interval
Disease
Economic growth
Economics
Fusion gene
Genetics